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Evaluation of Transcutaneous Electrical Nerve Stimulation as 
a Treatment of Neck Pain due to Musculoskeletal Disorders
 
Mikhled Maayaha, b, Mohammed Al-Jarraha
Abstract
Background: This study was designed to evaluate transcutaneous 
electrical nerve stimulation (TENS) as a treatment for neck pain 
due to musculoskeletal disorders within the context of a physio-
therapy treatment.
Methods:  Thirty subjects with neck pain were randomly allocated 
to two groups, treated with either TENS (n = 15) or placebo (n = 
15). Each subject received one session for one hour. All subjects 
were evaluated before, during treatment, after switch off and again 
a week after by using Myometer machine. All subjects completed 
the follow-up assessment. Subjects referred for out-subjects’ phys-
iotherapy department, fulfilling the inclusion and exclusion criteria, 
took part in the study.
Results:  The assessments were compared and used to measure 
outcome treatment. Improvement in their condition was measured 
in terms of a reduction in the individual’s level of pain during the 
week after the end of the first session. At the end of the first session, 
the study showed that 11 subjects (73%) in the treatment and 7 sub-
jects (43%) in the control groups had gained marked improvement. 
These results are statistically highly significant, (P = 0.01) at the 
end of the follow-up assessment.
Conclusions:  A conclusion could be drawn that a single intense 
TENS treatment is an effective treatment for neck pain due to mus-
culoskeletal disorders. On the other hand, TENS showed an effec-
tive pain relief with subjects who have a mild neck pain rather than 
those with severe symptoms.
Keywords:  Musculoskeletal disorders; Transcutaneous electrical 
nerve stimulation; Neck pain
Introduction
Neck pain is the second largest cause of time off work, after 
low back pain [1]. Pain is a major complaint of subject with 
neck pain due to musculoskeletal disorders of the cervical 
spine [2]. Neck pain from musculoskeletal disorders again 
tends to be worse in the morning and evening, with improve-
ment during the day. This pain often radiates to the shoulder, 
between the shoulder blades and up the neck to cause head-
aches [3]. The most commonly prescribed intervention for 
the treatment of neck pain by general practitioners is rest, 
followed by analgesics [4, 5]. Neck pain is one of the most 
common conditions for referral to a physical therapist. De-
spite the prevalence of neck pain, there is a lack of evidence 
for commonly used rehabilitation interventions [6]. 
There is various treatment options used to treat neck 
pain [7], for example, heat, massage, manipulation, cervical 
traction and supply of a cervical collar due to musculoskel-
etal disorders. Among them, transcutaneous electrical nerve 
stimulation (TENS) is widely available in Western chronic 
pain clinic [7]. Subjects may experience some relief from 
pain from these modalities but this improvement is rarely 
sustained, since subjects frequently return to the physicians 
without the problem solved. There would therefore appear to 
be a need for a means of controlling chronic neck pain.
TENS is a simple, noninvasive modality in physiothera-
py that is commonly used to control both acute and chronic 
pain arising from several conditions [8-12].  It was intro-
duced into clinical practice in 1972 as an adjunct to other 
pain therapies. The mechanism of the action of TENS is still 
not completely understood. Analgesia may be produced by 
the modulation of nociceptive input in dorsal horn of the spi-
nal cord by peripheral electrical stimulation of large sensory 
afferent nerves. This is the ‘gate control theory’ of pain [13]. 
Alternatively, electrical stimulation of certain receptor sites 
in the dorsal horn of the spinal cord may release endorphin, 
in turn, producing analgesia that can be reversed by nalox-
one [14, 15]. 
Several studies examined the efficacy of TENS in mus-
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culoskeletal disorders have been published. Since the 1970s, 
TENS has been gained popularity used as a treatment of 
acute and chronic pain [11, 16-18]. Transcutaneous electri-
cal nerve stimulation currently is one of the most commonly 
used forms of electroanalgesia [7]. In medicine, TENS is the 
most frequently used electrotherapy for producing pain re-
lief. 
A number of clinical studies exist concerning the use of 
TENS for various types of disorders such as low back pain 
[19-24], Myofascial [25] and arthritic pain [26], sympatheti-
cally mediated pain [26-28], bladder incontinence, neuro-
genic pain [29-32], visceral pain, and postsurgical pain [15, 
33, 34], chronic musculoskeletal pain [18, 35]. 
The chief advantage is that it is a non-invasive and non-
toxic form of pain management, which is based, in part, on 
the Gate Control Theory of pain [36]. It is thought to activate 
the large diameter, myelinated A-beta fibers which have a 




Outpatients with neck pain were recruited from physiother-
apy lab in Applied Medical Sciences at Jordan University 
of Science and Technology. The subjects had been clinically 
and radiologically diagnosed of neck pain due to musculosk-
eletal disorders. Further inclusion criteria for the study were 
aged between 20 to 75 years, neck pain existed most days in 
the last month. The subject should have received no treat-
ment for neck pain other than oral analgesia for the duration 
of one week after the end of the first session. And also sub-
ject should have had no previous TENS treatment.
Patients were excluded if they had any of the following: 
with a cardiac Pacemaker, since electrical impulses of the 
TENS may inhibit action; with history of malignancy, which 
could be a current cause of bone pain.
On arrival in the department, the study was explained 
to  eligible  subjects  with  neck  pain  and  written  informed 
consent  and  permission  to  enter  individual  subjects  was 
obtained. According to a block randomized allocation table 
(generated by sample size 2.0 Int), the enrolled subjects were 
allocated to either the TENS group or the placebo group.
Design
The design of this study was randomly controlled clinical 
trial using a block-randomized procedure. Each subject re-
ceived one session for one hour. All enrolled subjects were 
evaluated before, during treatment, after switch off and again 
a weak after by using Myometer machine.
Treatment
Control  group
The control group involved a TENS stimulator in working 
order, using a different set of leads in which contact was bro-
ken at the wire connecting the jack plug and the electrode 
pads. Thus, no stimulation passed to the subject’s skin, al-
though a small green light flash continued at the set pulse-
rate, reinforcing treatment. This mock TENS had no physi-
ological effect.  
TENS group
The TENS group subjects received one-hour treatment at 
the maximum tender area was marked with indelible ink to 
insure that all measurements were taken at the same point. 
The pulse-rate or frequency and amplitude or voltage is ad-
justable and a green light flashes at the selected pulse-rate. 
Two conductive silicone polymer electrodes were used for 
stimulation, attached to the TENS machine by a two cord 
lead, and to the skin with karaya pads electrodes. The karaya 
pad are conductive and once moistened become tacky allow-
ing the fixation of the electrodes without either jelly or tape. 
The subject was told that the electrodes were placed primar-
ily over tenders but where pain was diffused, the local acu-
puncture points around the neck were chosen for placement. 
Procedure was noted for each subject, but placement var-
ied when painful areas altered. When the electrodes were in 
place, the investigator turned on the machine. The intensity 
setting was regulated by the subject’s own comfort level and 
subjects were instructed to indicate when the level of stimu-
lation was at a comfortable and tolerable level. The subjects 
were instructed that the sensation should not be painful. Ad-
justments in the intensity were made during the session to 
maintain it at the same tolerable level. The frequency of the 
output was set at 4 - 8 Hz and current intensity was raised 
until the subject reported that it was unpleasant.
The subject was told that the TENS might or might not 
be effective and that the neck pain medication would be 
available as needed. All subjects reported a tolerable level 
of stimulation between 3 and 5 on the amplitude dial and the 
frequency 2 Hz. The investigator was available thought the 
sessions to discuss any functional difficulties related to neck 
pain due to musculoskeletal disorders.
Evaluation
Primary outcome measures were: (1) Self-assessment forms 
completed by the subject and the investigator; (2) Daily drug 
intake and daily pain level were recorded on a diary by the 
subject; (3) Self-assessment form to evaluate overall weekly 
pain, sleep disturbance and immediate response to treatment 
were recorded by the subject; (4) Neck pain  measured by 
Myometer machine. The Myometer scores were measured 
immediately before the first treatment and subsequently dur-
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ing treatment, after switch off and again a week after the 
completion of the first treatment. The subject removed suf-
ficient clothing to expose the cervical area and shoulder and 
sat on a chair. The Myometer was placed centrally, as far as 
possible, over the maximum tender area. The pressure ap-
plied by the investigator was indicated on a pressure trans-
ducer in kg - force and was gradually increased until a dis-
tinct painful sensation was elicited. This was taken as the 




Thirty subjects were recruited, 15 females, 15 males, aged 
21 - 70 years with mean of 55.7 years. Concerning duration 
of the neck pain problem, 48% of the subjects reported hav-
ing experienced mild gain for more than 5 years, with 3% of 
the subjects had experienced severe pain for 7 months, and 
20% indicating their pain had been quite severe for 5 years 
and 29% with a vague history of pain.
Group comparability
After separate randomization for male and female subjects, 
both groups contained equal numbers of subjects, (n = 15). 
The treatment group contained 8 female and 7 male subjects, 
and all completed the trial. The control group contained 7 
female and 8 male subjects and all completed the trial. 
Age of subjects in relation to treatment
The range of ages in the two groups was not similar: 23 - 70 
years in the treatment group and 35 - 72 years in the control 
group. The mean age of the treatment group was 53.53 years 
compared to 58.2 years in the control group. The distribu-
tions of age in the two groups are shown in Table 1.
Symptoms
All subjects had a single diagnosis of neck musculoskeletal 
disorders. The symptoms were for 8 subjects on the left side 
in the control group and for 4 subjects on the right side, the 
ratio of left to right was 2:1. The symptoms of pain in the 
treatment group are equal in left and right, and in both sides 
in both groups were equal (see Table 1). Although the left 
side of the neck, is the most common involvement area was 





Sex Male 8 7
Female 7 8
Age of subjects in relation to 
treatment
Range 35 - 72 23 - 70
Mean age (SD) 58 (8) 53 (7)
Mean Female Age (SD) 60 (9) 48 ( 6)
Mean Female Age (SD) 56.50 (7) 59 (8)
Symptoms Left 8 (53.30%) 6 (40%)
Right 4 (26.70%) 6 (40%)
Both 3 (20%) 63 (20%)
Severity of Symptoms Range for the all 11-35 11-35
Mean score for the all 19.66 19.66
Mean (SD) 21.47 (1 .43) 17.20 (1.15)
Analgesic Intake No analgesic drugs 8 10
Simple analgesia only 7 5
Table 1. Characteristics of the Demographic Data of the Study
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skeletal disorders was found to be greater among the treat-
ment group.
Severity of symptoms
Subjects were not divided into groups relating to symptom 
severity at the beginning of the trial. Although the method 
employed here is not a standard statistical procedure, the re-
sults obtained would appear to agree with the investigator’s 
subjective clinical opinion about each subject. The distribu-
tion of the total average of pain scores the week after the end 
of the first session in the two groups are shown in Table 1.
Analgesic intake
A record of analgesic intake was taken by each subject for 
one week after the end of the first session. This was to allow 
subjects to become stabilized on any drug they had recently 
been prescribed and also to establish the weekly score after 
the end of the first session. The type of drug for each subject 
was recorded. They were discouraged from altering the type 
of drugs they were taking, but they were encouraged to re-
duce the amount of analgesia where this was considered to 
be appropriate.
Subjects were either taking simple analgesia, such as 
Paracetamol or Brufen. No stronger analgesia was used by 
any subject during the week except one subject who was tak-
ing a strong analgesic for other medical purposes. A record 
of these was also kept. Table 1 indicates the intake of analge-
sia in the two groups.
Comparability of treatment and control groups
For the purposes of this study, it was necessary to obtain two 
similar groups of subjects so that the effects of treatment 
could be clearly evaluated and other variables excluded as 
far as possible.
The TENS and MTENS treatment groups appeared to 
be broadly comparable in sex, age, duration of present at-
tack, and severity of pain they had experienced before treat-
ment. Additionally, no subject was receiving any physio-
therapy treatment for neck musculoskeletal disorders except 
oral medication. The treatment and control groups therefore 
seemed to be similar for the variables analyzed. All the sub-
jects received one session of 60 minutes duration. All sub-
jects received similar instructions and explanations prior to 
beginning the trial. All subjects completed self-assessment 
forms, and all measurements were carried out by the inves-
tigator. It was therefore assumed that any variation in the 
results was obtained from the effects of TENS.
Summary of data collection
Information concerning the efficacy of TENS treatment was 
obtained from subjects as the following: 
1.      Self-assessment forms completed by the subject and 
No improvement Improvement
Treatment 3 (20%) 11 (73.33%) 1 (6.67%)
Control 8 (53.33%) 7 (46.67%) 0 (-)
Table 2. Result at One Week After the First Session
Worse
Figure 1. Results of treatment at one week after the first session.
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the investigator
2.      Daily drug intake and daily pain level were recorded 
on a diary
3.      Self-assessment form to evaluate overall weekly pain, 
sleep disturbance and immediate response to treatment.
4.      Neck pain  measured by Myometer machine.
Results of data collection
Initially results were analyzed to determine success in relief 
of pain. All information used in the analysis of treatment was 
obtained from the self-assessment forms. The week after the 
first session, 11 subjects in the TENS group and 3 subjects in 
the control group showed a marked improvement. One sub-
ject in the treatment group was considered to be worse after 
the first three days after the end of the first session (Table 2 
and Fig. 1).
Short-term of pain relief
Following the end of the first session, no further treatment 
was given to any subject. After one week, all subjects were 
followed up to reassess their condition. During the follow-
up period, subjects continued to keep a daily record of their 
drug intake and pain levels. The subjects completed a final 
self-assessment form on the follow-up visit.
Of the all subjects in the treatment group who showed 
marked pain relief after one week from the end of the first 
session, 2 showed marked pain relief during the treatment 
and 2 showed marked improvement after 30 minutes to 2 
 Table 3. Duration of Short-term Pain Relief Following Cessation of TENS
Table 4.  Pain Threshold Measurements for Both Groups
   131                                   132J Clin Med Res  •  2010;2(3):127-136 Maayah et al
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press™   |   www.jocmr.org
hours. Of the 8 subjects in the control group who showed 
no marked pain relief during the session, 4 showed marked 
pain relief after more than 2 hours and the other 3 subjects 
showed marked pain relief after 30 minutes. Table 3 shows 
the duration of short-term pain relief following cessation Of 
TENS. 
Statistical analysis of results
No statistical test was carried out for the results after the end 
of the first session. The difference in response to treatment 
between the treatment and control groups were obviously sta-
tistically significant. After one week of treatment, 11 (73%) 
subjects in the treatment group had showed marked pain re-
lief compared to 7 (47%) subjects in the control group. The 
following statistics showed pain threshold measurements for 
both groups (Table 4). The mean pain threshold before the 
session in the treatment group is less than the control group 
(Table 4 and Fig. 2).
Mean pain threshold values for each group before, dur-
ing, after, and after a week are shown in Table 4 and Figure 2. 
The analysis of variance (ANCOVA) showed a statistically 
significant interaction between groups and before, during, af-
ter switch off and after a week follow-up (Table 5), therefore, 
a statistically significant difference existed among the groups 
in the terms of mean before and week after pain threshold 
changes.  Using ANCOVA  showed  statistically  significant 
difference (p <  0.01) between the time (before and 1 week 
Figure 2. Results of pain threshold measurements for both groups.
Table 5. Analysis of Variance for Pain Threshold
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after) and treatment for both groups (Table 5).
Discussion
  
The results of this study were statistically significant, and 
especially show that TENS diminishes the pain experienced 
in the cervical area due to musculoskeletal disorders. The 
comparison of the effects of TENS and the effect of the pla-
cebo was dependent upon the similarity of the subjects in the 
two groups.
The present study demonstrated that TENS treatment 
was effective in pain relief. TENS is a popular modality 
for treating musculoskeletal pain [38]. TENS excited large-
diameter afferent fibers [13]. According to the gate control 
theory [39], TENS may stimulate the large-diameter afferent 
fibers, which may reduce the transmission of pain signals 
through the small nociceptive afferent fibers, thereby inhibit-
ing pain discrimination and perception. 
Symptom severity
Little is known about the effects of TENS on similar condi-
tion of varying severity. It has been suggested that the great-
est pain relief is reported after TENS in subjects who have 
received minimal previous medical treatment [7]. 
However, it is possible that those subjects with a long 
standing  history  at  musculoskeletal  disorders  could  have 
received a greater number of medical treatments than those 
with a shorter history of disease, and that they might respond 
less well to treatment. It was not possible to obtain an ac-
curate history of previous treatment in all cases. It became 
obvious as the trial proceeded that those subjects with more 
severe symptoms gained less pain relief than those with mild 
disease. Following completion of the trial, all the available 
information regarding factors which might reasonably be as-
sociated with disease severity were considered, and subjects 
were divided into groups  (Table 1).
Use of single-blind methods
Ideally, the investigator should have been blind as to which 
treatment each subject was receiving. The use of mock elec-
trical stimulation meant that ‘stimulation’ levels were preset 
and no adjustment was necessary. It was therefore impos-
sible for the investigator to be “blind” to treatment. Every 
attempt was made to ensure that treatment procedures were 
the same for each subject.
Self-assessment
The  difficulty  in  accurately  assessing  pain  [40]  is  well 
known, especially using a practical method in a busy clinical 
situation, yet such a system is essential for the evaluation of 
methods controlling pain. 
The word pain refers to an endless variety of quantities 
that are categorized under one label, and not to a single spe-
cific entity [40, 41].  A number of methods have been de-
signed to evaluate uncontrolled chronic pain.
It is described by the author as being sufficiently sensi-
tive to detect differences among different methods of treat-
ing pain, and has been successfully employed to measure 
changes in pain quality and intensity produced by TENS 
[42]. However, the questionnaire is long, detailed and is not 
a practical tool within the confines of a busy department. It 
has already been suggested that a subjective measurement of 
the greatest importance, since only the subject experiences 
the painful sensations.
Analgesia
During the week after the end of the first session subjects 
were asked not to alter their drug which they were taking, 
but to reduce their analgesic intake whenever it was possible 
and appropriate. Only one subject altered of type of the drug 
during the subsequent week. Ideally all subjects should have 
been prescribed the same type of analgesic, but this was not 
possible within the time available and within the methodol-
ogy of the trial.
Application of the trial results
The result of this study suggests that TENS is an effective 
means of relieving pain in the neck due to musculoskeletal 
disorders. TENS was used in the context of a physiotherapy 
treatment. The results show a statistically significant result in 
the treatment group while no improvement was shown in the 
control group. It would seem that TENS could usefully be 
employed in the treatment of some cases of musculoskeletal 
pain. The use of a non-invasive technique, such as TENS 
to control musculoskeletal pain could provide a useful al-
ternative to the use of large amounts of potentially harm-
ful analgesic drugs, especially if sustained pain relief can be 
achieved.
The result of this study stated that in some conditions it is 
possible to gain much marked pain relief for up to one week 
following the end of the first session. There is no certainty 
whether or not the analgesic effect was sustained after this 
time, since no further follow-up was attempted. However the 
method of the application of TENS in this study was flexible. 
Treatment was limited to one session. Prolonged courses or 
more frequent application of treatment may produce marked 
pain relief in greater percentage of subjects.
The immediate short-term or long-term analgesic effect 
of TENS could also be usefully employed in treating muscu-
loskeletal disorders, in conjunction with other physiotherapy 
modalities such as traction and mobilization. Most TENS 
machines are battery operated and portable, which the sub-
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jects are able to move whilst the electrodes are in place. Min-
imal side-effects and the simplicity of the TENS machines is 
appropriate as a home or self-treatment modality.
The TENS units are also relatively inexpensive. For the 
above reasons, any subject could buy one and with some in-
struction by a physiotherapist, could use it safely. Subjects 
could therefore purchase a machine for use at home for long-
term pain relief. This could have positive effect upon Health 
Services Finance as this alternative might reduce the need 
for out subject attendances for physiotherapy and consump-
tion of expensive drugs. The use of TENS as a treatment for 
musculoskeletal disorders of the neck symptoms could com-
pletely relieve severe pain in some cases. TENS could also 
be effective in treating other joints affected by musculoskel-
etal disorders or in other forms of arthritis.
Group comparability
The analysis of characteristics of the two groups, showed 
them to be similar. Both treatment and control groups con-
tained 15 subjects, male and female. The mean age of the 
control group was greater than that of the treatment group, 
but age is not thought to affect the response to treatment. Age 
distribution of subjects in the two groups was similar (Table 
1), and analgesic intake was comparable in the two groups, 
(Table 1). Duration of the symptoms was slightly greater in 
the control group, although a small proportion of the treat-
ment and control group had bilateral symptoms (Table 1). 
The two groups were thought to be comparable for symptom 
severity (Table 1). The similarity of the two groups meant 
that any variation in their response to treatment could rea-
sonably be attributed to the treatment they received. There-
fore differences shown in the result between the treatment 
and control groups can be assumed to be associated with the 
effects of TENS treatment. 
Result of treatment
Self-assessment forms and daily analgesic intake diaries and 
degree of sleep disturbances for each subject were used to 
obtain a pain score one week after the end of the first session. 
One week after the end of the first session, 12 (80%) subjects 
in the treatment group, 7 (47%) subjects of the control group 
had shown marked pain relief within the criteria laid down 
for improvement. This suggests that TENS is effective as a 
means of relieving musculoskeletal disorders pain in most 
cases, substantially supporting the initial hypothesis.
The result also describes the short-term effects of TENS 
and suggests that TENS can produce sustained relief from 
musculoskeletal disorders pain. However, 73% of subjects 
in the treatment group reported an immediate response to 
TENS. Although this ‘long-term’ relief of pain is not ana-
lyzed or described in any detail in this study, it is an impor-
tant feature of TENS. Nevertheless the short-term relief of 
pain has been demonstrated in both treatment and control 
groups as 67% of subjects reported an immediate response 
to treatment. The psychological effect of receiving treatment 
or attending the physiotherapy department may have contrib-
uted to this, as may contact with the therapist. All subjects 
were aware that they were taking part in a research project 
and this might have influenced the result.
The results obtained from this study are statistically sig-
nificant at the 5% level, as they suggest that TENS is more 
effective than placebo in relieving musculoskeletal disorders 
pain experienced in the neck. The small number of subjects 
in the study sample can only be supposed to be representative 
of the population of subjects with musculoskeletal disorders.
Relevance of trial methodology
The over all objective of the trial was to evaluate the efficacy 
of TENS as a means of relieving musculoskeletal pain in the 
neck. In order to achieve these objectives, a single blind, ran-
domized controlled clinical trial was selected. 
TENS versus placebo
The comparison between TENS and mock electrical stimula-
tion has been evaluated as a valid method of determining the 
effects of TENS [41]. In order to distinguish the real effect of 
TENS from that of the placebo effect incurred in a physical 
treatment, a machine giving mock TENS was used as a con-
trol treatment. Also, by using a machine of similar appear-
ance, with identical treatment procedure, any difference in 
response between two comparable groups can reasonably be 
attributed to the electrical stimulation, and not to the place-
ment of electrodes on the skin or the use of a previously un-
known treatment or treatment procedure.
Finally, the treatment and placebo machines were almost 
one machine has used, with one producing a ‘tingling’ sensa-
tion effect and the other producing no abnormal sensation on 
the skin. It was therefore decided that the most appropriate 
method of evaluating the effect of TENS as treatment for 
musculoskeletal disorders, was to compare its effects with 
those of a placebo in two comparable groups of subjects. It 
was difficult to obtain similar groups of subjects within the 
time available to conduct the trial. Subjects were considered 
for entry as they were referred to the department, and it was 
not possible to match subjects for symptoms and age or to 
compare the two departments.
Conclusions
                                                                                              
The present study demonstrated that TENS has shown an ef-
fective means of providing a sustained pain relief in terms of 
Myometer machine in subjects complaining from neck pain 
due to musculoskeletal disorders. On the other hand, TENS 
may show an effective pain relief with subjects who have a 
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mild pain. TENS is a useful physiotherapy technique in the 
management of musculoskeletal disorders, but also has a po-
tential use in primary medical care as a means of home treat-
ment where pain relief can not be sustained by drugs. TENS 
could be used as pain relief to reduce the amount of analgesic 
drugs taken by subjects, especially for prolonged symptoms. 
In comparison with other physiotherapy equipment, the 
TENS stimulator is compact, cheap, simple to administer, 
relatively safe to use and free side effects. The pain relief ob-
tained by using TENS does not always last as long as subject 
would like. It can vary from a few weeks to a few months up 
to several years.
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